Systematic Review and Meta-analysis of the Prevalence of Group A Streptococcal emm Clusters in Africa To Inform Vaccine Development
Open Access
- 1 July 2020
- journal article
- research article
- Published by American Society for Microbiology in mSphere
- Vol. 5 (4)
- https://doi.org/10.1128/mSphere.00429-20
Abstract
An emm-cluster based system was proposed as a standard typing scheme to facilitate and enhance future studies of group A Streptococcus (GAS) epidemiological surveillance, M protein function, and vaccine development strategies. We provide an evidence-based distribution of GAS emm clusters in Africa and assess the potential coverage of the new 30-valent vaccine in terms of an emm cluster-based approach. Two reviewers independently assessed studies retrieved from a comprehensive search and extracted relevant data. Meta-analyses were performed (random-effects model) to aggregate emm cluster prevalence estimates. Eight studies (n = 1,595 isolates) revealed the predominant emm clusters as E6 (18%; 95% confidence interval [CI], 12.6% to 24.0%), followed by E3 (14%; 95% CI, 11.2% to 17.4%) and E4 (13%; 95% CI, 9.5% to 16.0%). There was negligible variation in emm clusters with regard to regions, age, and socioeconomic status across the continent. Considering an emm cluster-based vaccine strategy, which assumes crossprotection within clusters, the 30-valent vaccine currently in clinical development would provide hypothetical coverage to 80.3% of isolates in Africa. This systematic review indicates the most predominant GAS emm cluster in Africa is E6 followed by E3, E4, and D4. The current 30-valent vaccine would provide considerable coverage across the diversity of emm cluster types in Africa. Future efforts could be directed toward estimating the overall potential coverage of the new 30-valent vaccine based on cross-opsonization studies with representative panels of GAS isolates from populations at highest risk for GAS diseases. IMPORTANCE Low vaccine coverage is of grave public health concern, particularly in developing countries where epidemiological data are often absent. To inform vaccine development for group A Streptococcus (GAS), we report on the epidemiology of the M protein emm clusters from GAS infections in Africa, where GAS-related illnesses and their sequelae, including rheumatic fever and rheumatic heart disease, are of a high burden. This first report of emm clusters across the continent indicates a high probably of coverage by the M protein-based vaccine currently undergoing testing were an emm-cluster based approach to be used.Funding Information
- HHS | National Institutes of Health (R01 AI-132117, R01 AI-010085)
- American Heart Association (NW17SFRN33630027)
- National Research Foundation (116287)
This publication has 40 references indexed in Scilit:
- Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreementJournal of Clinical Epidemiology, 2012
- New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococciVaccine, 2011
- Developing a geographic search filter to identify randomised controlled trials in Africa: finding the optimal balance between sensitivity and precisionHealth Information and Libraries Journal, 2011
- Epidemiological markers of Streptococcus pyogenes strains in TunisiaClinical Microbiology & Infection, 2011
- Maternal sepsis: epidemiology, etiology and outcomeCurrent Opinion in Infectious Diseases, 2010
- Comparative analysis of emmtype pattern of Group A Streptococcus throat and skin isolates from India and their association with closely related SIC, a streptococcal virulence factorBMC Microbiology, 2008
- M Protein Gene ( emm Type) Analysis of Group A Beta-Hemolytic Streptococci from Ethiopia Reveals Unique PatternsJournal of Clinical Microbiology, 2005
- Contrasting Molecular Epidemiology of Group A Streptococci Causing Tropical and Nontropical Infections of the Skin and ThroatThe Journal of Infectious Diseases, 2000
- The Reemergence of Serious Group A Streptococcal Infections and Acute Rheumatic FeverThe American Journal of the Medical Sciences, 1996